Sutro Biopharma, Inc.
STRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,693 | $63,745 | $17,399 | $14,809 |
| % Growth | -84.8% | 266.4% | 17.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $9,693 | $63,745 | $17,399 | $14,809 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $39,853 | $38,325 | $51,597 | $71,037 |
| G&A Expenses | $8,741 | $10,343 | $13,273 | $9,030 |
| SG&A Expenses | $8,741 | $10,343 | $13,273 | $9,030 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $9,558 | $18,422 | $21,043 | $0 |
| Operating Expenses | $58,152 | $67,090 | $85,913 | $80,067 |
| Operating Income | -$48,459 | -$3,345 | -$68,514 | -$65,258 |
| % Margin | -499.9% | -5.2% | -393.8% | -440.7% |
| Other Income/Exp. Net | -$8,398 | -$8,172 | -$7,454 | -$4,830 |
| Pre-Tax Income | -$56,857 | -$11,517 | -$75,968 | -$70,088 |
| Tax Expense | $0 | -$18 | $0 | $2,355 |
| Net Income | -$56,857 | -$11,499 | -$75,968 | -$72,443 |
| % Margin | -586.6% | -18% | -436.6% | -489.2% |
| EPS | -6.7 | -1.4 | -9.1 | -8.8 |
| % Growth | -378.6% | 84.6% | -3.4% | – |
| EPS Diluted | -6.7 | -1.4 | -9.1 | -8.8 |
| Weighted Avg Shares Out | 8,487 | 8,458 | 8,311 | 8,253 |
| Weighted Avg Shares Out Dil | 8,487 | 8,458 | 8,311 | 8,253 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,009 | $2,519 | $3,189 | $3,860 |
| Interest Expense | $10,407 | $9,647 | $10,643 | $8,690 |
| Depreciation & Amortization | $1,900 | $1,900 | $1,900 | $1,868 |
| EBITDA | -$44,550 | $1,074 | -$45,571 | -$59,530 |
| % Margin | -459.6% | 1.7% | -261.9% | -402% |